Comment
Author: Admin | 2025-04-28
Scholar in Nephrology Research at the IU School of Medicine, studies the relationship between transcriptomic and genomic markers to help improve drug efficacy and adverse events relevant in kidney disease. "IU School of Medicine provides a vibrant academic environment," Eadon said. "To have three inductees this year shows that IU is committed to developing and retaining its investigators. I am proud to represent IU School of Medicine nephrology and clinical pharmacology in the ASCI." Hato, an associate professor of medicine at the IU School of Medicine, studies the cellular and molecular mechanisms of sepsis-associated acute kidney injury, the most common kidney problem in hospital settings. "I am deeply grateful to my mentors, colleagues, and the research community for their support and inspiration," Hato said. "This is a tremendous honor that reinforces my commitment to advancing biomedical research and contributing to the success of others in the field."IU School of Medicine faculty previously inducted into the ASCI include Liana Apostolova, Carmella Evans-Molina, David Hains, Asok C. Antony, David M. Aronoff, Karl Bilimoria, D. Craig Brater, Naga Chalasani, D. Wade Clapp, David Crabb, Michael J. Econs, Tarek M. Ashkar (El-Achkar), Laura S. Haneline, Jay L. Hess, David A. Ingram Jr., Roberto F. Machado, Meena Madhur, Sharon M. Moe, Bruce A. Molitoris, G. David Roodman, Stanley M. Spinola, Stephanie M. Ware and Michael A. Weiss.About the Indiana University School of MedicineThe IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability. According to the Blue Ridge Institute for Medical Research, the IU School of Medicine
Add Comment